Description
Description du produit
Cabergoline was first approved for marketing in the United States in 1999, and the latest prescribing information was updated in April 2025.
Informations de base
Chinese name: Camembert
English name: Cabergoline
Common name: Cabergoline
Product specifications: 0.5mg * 8 tablets/box
Fabricant: Lucius Pharmaceuticals
Mailing method: Hong Kong
Indications
It is indicated for the treatment of hyperprolactinemia in adults, including those with idiopathic or pituitary adenoma-related conditions.
Administration and Posologie
Please use the product according to the instructions, the pharmacist's review, or the doctor's advice; do not adjust the dosage on your own.
Important Notes
Before purchasing and using the product, please verify your personal health status and the product's scope of application; if you have underlying medical conditions, a history of allergies, or are currently taking medication, please consult a professional first.
